| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |